Healthleap, which makes AI screening software that helps identify patients at risk of undiagnosed illnesses, raised $38M across a $30M Series A and an $8M seed

AI can now identify undiagnosed conditions from unstructured doctor's notes, unlocking significant hospital revenue and improving patient care.

Healthleap, a health tech startup, has secured $38 million in funding, comprising an $8 million seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. Founded in 2022, Healthleap developed an AI platform that analyzes patient electronic health records, including unstructured clinical notes, to identify individuals at risk for undiagnosed conditions like malnutrition and delirium. The software flags these patients for closer review by care teams, aiming to improve patient outcomes and hospital efficiency. Currently deployed in over 50 hospitals, including major institutions like Penn Medicine and Cedars-Sinai, Healthleap reports a tenfold increase in revenue over the past year. The company plans to use the new capital to expand its engineering, product, sales, and customer success teams, with ambitions to cover more than 40 health conditions and extend its services to outpatient and home care settings.

Healthleap's success highlights a growing trend of AI solutions moving beyond structured data to interpret unstructured clinical narratives, a significant advancement in healthcare analytics. This capability allows for the early detection of conditions often missed in routine screenings, potentially impacting patient recovery times and reducing hospital readmissions. The company's impressive customer adoption, growing from three to over 50 hospital partners in a year, suggests a strong market demand for AI tools that can demonstrate tangible financial returns and improve care quality.

The substantial funding rounds for Healthleap underscore investor confidence in AI's ability to address critical gaps in healthcare delivery and management. Companies that can effectively integrate with existing electronic health record systems and provide demonstrable ROI are well-positioned for growth. The focus on conditions like malnutrition and delirium, which have substantial downstream costs, indicates a strategic market entry that appeals to hospital administrators focused on both patient outcomes and financial efficiency.